Immunological outcomes between Tenofovir versus Zidovudine-based regimens: a retrospective cohort study

• Hoofdauteurs: Meshack Lugoba1 (Auteur), Manase Kilonzi1 (Auteur), George M Bwire2 (Auteur), Pacifi que Ndayishimiye1 (Auteur), Wigilya P Mikomangwa1 (Auteur), Hamu J Mlyuka1 (Auteur), Alphonce I Marealle1 (Auteur), Ritah F Mutagonda1 (Auteur), Kennedy D Mwambete2 (Auteur)
• Formaat: Boek
• Gepubliceerd in: Archives of Community Medicine and Public Health - Peertechz Publications, 2019-07-11.
• Onderwerpen: Research Article
• Online toegang: Connect to this object online.

<p><strong>Background</strong>: Since 2013, Tenofovir (TDF) and Zidovudine (AZT) based regimen are alternatively used as a fi rst line for treatment of HIV in Tanzania. CD4+ cells count, which is recommended after every six months monitors the immunological progression, and used as...